Recce Pharmaceuticals (ASX:RCE) and the significant value of the clinical trial process
It can take a long time to bring a new drug to market, but companies that…
| Change | ||
| S&P/ASX Sm. Ords. | |||
| All Ordinaries | |||
| S&P/ASX 100 |
| VBC | Verbrec Limited | 23.5¢ | 27.0% |
| RGT | Argent BioPharma Ltd | 3.4¢ | 21.4% |
| EGY | Energy Technologies Ltd | 2.4¢ | 20.0% |
| TSK | Tusker Minerals Ltd | 5.0¢ | 21.9% |
| R8R | Regener8 Resources NL | 8.0¢ | 20.0% |
| CHW | Chilwa Minerals Ltd | 73.0¢ | 19.8% |